CA1044141A - Hypertensive composition - Google Patents

Hypertensive composition

Info

Publication number
CA1044141A
CA1044141A CA233,279A CA233279A CA1044141A CA 1044141 A CA1044141 A CA 1044141A CA 233279 A CA233279 A CA 233279A CA 1044141 A CA1044141 A CA 1044141A
Authority
CA
Canada
Prior art keywords
composition
diuretic
alkyl
hydroxypropoxy
thiadiazole
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
CA233,279A
Other languages
English (en)
French (fr)
Inventor
Charles S. Sweet
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merck and Co Inc
Original Assignee
Merck and Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck and Co Inc filed Critical Merck and Co Inc
Application granted granted Critical
Publication of CA1044141A publication Critical patent/CA1044141A/en
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
CA233,279A 1974-08-16 1975-08-12 Hypertensive composition Expired CA1044141A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US49796174A 1974-08-16 1974-08-16
US55437375A 1975-03-03 1975-03-03

Publications (1)

Publication Number Publication Date
CA1044141A true CA1044141A (en) 1978-12-12

Family

ID=27052662

Family Applications (1)

Application Number Title Priority Date Filing Date
CA233,279A Expired CA1044141A (en) 1974-08-16 1975-08-12 Hypertensive composition

Country Status (10)

Country Link
AU (1) AU505455B2 (US07118763-20061010-C00002.png)
CA (1) CA1044141A (US07118763-20061010-C00002.png)
CY (1) CY978A (US07118763-20061010-C00002.png)
DE (1) DE2536349A1 (US07118763-20061010-C00002.png)
FR (1) FR2281757A1 (US07118763-20061010-C00002.png)
GB (1) GB1495034A (US07118763-20061010-C00002.png)
HK (1) HK73178A (US07118763-20061010-C00002.png)
KE (1) KE2903A (US07118763-20061010-C00002.png)
MY (1) MY7900033A (US07118763-20061010-C00002.png)
NL (1) NL7508856A (US07118763-20061010-C00002.png)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ192673A (en) * 1979-02-02 1984-07-06 Merck & Co Inc Ophthalmic compositions for lowering intraocular pressure
IE50901B1 (en) * 1980-03-04 1986-08-06 Merck & Co Inc Ophthalmic compositions of carbonic anhydrase inhibitors for topical application in the treatment of elevated intraocular pressure
US4898729A (en) * 1983-12-09 1990-02-06 Euroceltique, S.A. Treatment of hypertension, compounds and compositions for antihypertension and diuresis

Also Published As

Publication number Publication date
AU8371375A (en) 1977-02-10
CY978A (en) 1979-03-23
FR2281757A1 (fr) 1976-03-12
FR2281757B1 (US07118763-20061010-C00002.png) 1980-04-11
NL7508856A (nl) 1976-02-18
KE2903A (en) 1978-12-01
DE2536349A1 (de) 1976-02-26
GB1495034A (en) 1977-12-14
AU505455B2 (en) 1979-11-22
HK73178A (en) 1978-12-22
MY7900033A (en) 1979-12-31

Similar Documents

Publication Publication Date Title
DE69435039T2 (de) Verwendung von thiazolidindionen zur vorbeugung oder verzögerung des auftretens des nichtinsulinabhängigen diabetes mellitus (niddm)
CA2515343A1 (en) Antiparasitic terpene alkaloids
EP0622076B1 (en) Inhibitor for restenosis after percutaneous coronary arterioplasty
PL195140B1 (pl) Kompozycja farmaceutyczna zawierająca 5-[4-[2-(N-metylo-N-(2-pirydylo)amino)etoksy]-benzylo] tiazolidyno-2,4-dion i jej zastosowanie
EP0051706B1 (en) Gelatin capsule dosage unit containing triamterene
CA1044141A (en) Hypertensive composition
JP4306825B2 (ja) インスリン抵抗性が関与する血管機能異常を伴う疾患の予防または治療剤
KR20010013843A (ko) 로지글리타존 및 인슐린을 사용한 당뇨병의 치료
US4178374A (en) Novel pharmaceutical compositions of β-blockers with diuretics
JPH11302177A (ja) 腎炎治療剤
US4238485A (en) Novel pharmaceutical compositions
KR20010013410A (ko) 5-[4-[2-(ｎ-메틸-ｎ-(2-피리딜)아미노)에톡시]벤질]티아졸리딘-2,4-디온을 함유하는 조성물
JPS62132826A (ja) 抗高血圧剤
US3549754A (en) Combination of 2-substituted benzimidazoles and substituted phenothiazines in the treatment of helminthiasis
IE70332B1 (en) Antiallergic combination
US6069147A (en) Thermogenesis stimulating drugs
US3833727A (en) Hydralazine and beta-adrenergic blocking agent compositions for treating hypertension
MY160429A (en) 2, 5-disubstituted 3-mercaptopentanoic acid
CA1069049A (en) COMBINATION OF .beta.-BLOCKER AND INDANONE WITH OR WITHOUT AMILORIDE
EP0452697B1 (en) Stabilizer for 4-ethyl-2-hydroxyimino5-nitro-3-hexenamide-containing preparation and stabilizing method therefor
CA2148502A1 (en) Antidepressants
KR100189708B1 (ko) 혈당 저하제
CN108774220B (zh) 用于治疗心肌缺血的化合物及其应用
GB1584089A (en) Antihypertensive pharmaceutical compositions
JPS59205318A (ja) コデルゴクリンとカルシウム拮抗剤からなる製剤